Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Hippo Holdings Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
51.6
91.2
120
210
372
469
Selling and marketing
69.4
95
102
80.1
51.2
33.5
General and administrative
36.8
49.2
71.5
79.6
70.7
67.1
Pre-tax income
-143
-367
-325
-263
-27.4
63.3
Income tax
-1.8
0.7
1.3
0.5
1.2
0.7
Net income to minority interests
0.1
3.5
6.9
10.1
11.9
4.9
Net income
-142
-371
-333
-273
-40.5
57.7
EPS, basic
-40.88
-34.11
-14.66
-11.58
-1.64
2.28
EPS, diluted
-40.88
-34.11
-14.66
-11.58
-1.64
2.22
Shares, basic (weighted)
3.46
10.9
22.7
23.6
24.7
25.3
Shares, diluted (weighted)
3.46
10.9
22.7
23.6
24.7
26
Balance sheet
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
452
776
195
142
198
218
Short-term investments
0
9.1
325
187
Other current assets
1.07
Total current assets
1.7
Property, plant and equipment
1.1
5.4
34.9
33
31.6
Lease right-of-use assets
0
27.6
10.6
4.7
1.6
Goodwill
47.8
53.5
0
0
0
Intangible assets
33.9
32.2
26.9
27.3
17
13.8
Long-term investments
56
54.9
121
162
Total assets
979
1,643
1,569
1,525
1,543
1,906
Accrued liabilities
0.14
Total current liabilities
0.15
Total liabilities
834
781
975
1,140
1,178
1,469
Paid-in capital
56.9
1,488
1,558
1,615
1,640
1,652
Retained earnings
-257
-628
-961
-1,234
-1,275
-1,217
Other comprehensive income
0.1
-0.7
-7
-2.9
-2.7
1.8
Shareholders' equity
-200
860
590
378
362
436
Minority interests
0.1
2.1
3.6
6.8
3.1
0
Total equity
-200
862
594
385
365
436
Total liabilities and equity
979
1,643
1,569
1,525
1,543
1,906
Shares outstanding
3.69
22.6
23.2
24.1
24.9
25.7
Cash flow statement
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-141
-368
-327
-263
-28.6
62.6
Depreciation and amortization
6.7
11
15.2
19.8
23.2
20.4
Stock-based compensation
17.2
24.3
61.9
57.5
38.2
29.3
Deferred income tax
-2
0
0
-0.7
0.1
0.7
Change in receivables
-14.7
-19.5
-50.9
-38
-21.9
-85.4
Cash from operations
-65.4
-125
-162
-92.4
47.5
9.2
Capital expenditures
-0.4
-0.8
-4.9
-29.6
-0.3
-0.1
Acquisitions
-83.7
-0.6
Purchases of investments
-16.7
-26.2
-88.8
-55.3
-97.7
-138
Sales and maturities of investments
76.8
5.8
10.2
15.6
49.1
51.6
Cash from investing
-2.3
-30
-406
57.6
30.3
-11.2
Stock issued
2.4
5.5
4.1
2.8
6.7
3.8
Share buybacks
0
-1.8
-15.6
-14.5
Cash from financing
518
481
-6.8
-14.6
-40.1
19.3
Net change in cash
450
326
-574
-49.4
37.7
17.3
Free cash flow
-65.8
-125
-166
-122
47.2
9.1
Income taxes paid
0.7
2.2
1.3
0.3
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $30.61 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Pre-tax margin
24.3%
Pre-tax income / revenue.
Net margin
23.9%
Net income / revenue.
FCF margin
14.1%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
14.1%
Cash from operations / revenue.
Effective tax rate
1.5%
Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)
5.2%
Net income / average total assets.
Stock-based pay / revenue
5.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.1%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
25.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
57.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
55.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y
-80.6%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-80.7%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
20.4%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-9.6%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
23.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
6.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
14.2%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
5.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
4.6%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
49.7%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Liabilities / assets
79.9%
Total liabilities / total assets.
Goodwill and intangibles / assets
0.6%
(Goodwill + intangible assets) / total assets.
Efficiency
Metric
Value
How it is calculated
Asset turnover
0.22x
Revenue / average total assets.
Fixed asset turnover
16.3x
Revenue / average property, plant and equipment.
FCF conversion
58.9%
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
0.4%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$4.57
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Market cap + total debt - cash - short-term investments.
P/E
6.66x
Market cap / net income. Only when net income is positive.
P/S
1.59x
Market cap / revenue.
P/FCF
11.3x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
11.3x
Market cap / cash from operations, when positive.
EV/Sales
1.11x
Enterprise value / revenue.
EV/FCF
7.89x
Enterprise value / free cash flow, when both are positive.
FCF yield
8.8%
Free cash flow / market cap.
Earnings yield
15.0%
Net income / market cap (the inverse of P/E).
What was Hippo Holdings Inc.'s revenue in fiscal 2025?
Hippo Holdings Inc. reported revenue of $468.6M for fiscal 2025, 25.9% higher than the year before.
Was Hippo Holdings Inc. profitable in fiscal 2025?
Yes. Net income was $57.7M, a net margin of 12.3%.
How much free cash flow did Hippo Holdings Inc. generate in fiscal 2025?
Cash from operations of $9.2M minus capital expenditures of $100.0K left free cash flow of $9.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.